Table 2

Comparison of diastolic and systolic intraventricular pressure difference parameters between the groups

VariableNo-HF
(n=159)
HFrEF
(n=47)
HFpEF
(n=32)
P value
Unadjusted model
E-IVPD (mm Hg)0.76 (0.68, 0.84)0.83 (0.67, 0.98)0.83 (0.64, 1.02)0.63
ER-IVPD (mm Hg)−0.78 (−0.93, −0.63)−0.75 (−1.02, −0.47)−1.30 (−1.60, −0.99)0.01*†
A-IVPD (mm Hg)0.93 (0.85, 1.02)0.72 (0.56, 0.88)0.92 (0.73, 1.11)0.07
S-IVPD (mm Hg)1.7 (1.56, 1.84)1.41 (1.16, 1.65)1.99 (1.65, 2.34)0.01†
SR-IVPD (mm Hg)−1.15 (−1.28, −1.02)−0.90 (−1.17, −0.64)−1.37 (−1.64, −1.10)0.04†
Adjusted model 1
E-IVPD (mm Hg)0.75 (0.65, 0.85)0.86 (0.64, 1.08)0.85 (0.61, 1.08)0.70
ER-IVPD (mm Hg)−0.76 (−0.95, −0.56)−0.85 (−1.23, −0.47)−1.35 (−1.72, −0.97)0.02*
A-IVPD (mm Hg)0.94 (0.83, 1.05)0.71 (0.49, 0.92)0.94 (0.70, 1.17)0.15
S-IVPD (mm Hg)1.7 (1.52, 1.89)1.49 (1.14, 1.84)1.89 (1.47, 2.3)0.16
SR-IVPD (mm Hg)−1.15 (−1.32, −0.98)−0.94 (−1.30, −0.58)−1.34 (−1.67, −1)0.14
Adjusted model 2
E-IVPD (mm Hg)0.84 (0.71, 0.97)0.93 (0.67, 1.19)0.79 (0.54, 1.04)0.62
ER-IVPD (mm Hg)−0.68 (−0.92, −0.45)−0.99 (−1.41, −0.56)−1.48 (−1.87, −1.08)0.009*
A-IVPD (mm Hg)0.97 (0.84, 1.11)0.75 (0.50, 1.00)0.97 (0.72, 1.22)0.27
S-IVPD (mm Hg)1.72 (1.49, 1.96)1.46 (1.03, 1.89)1.86 (1.39, 2.33)0.25
SR-IVPD (mm Hg)−1.17 (−1.34, −0.99)−0.83 (−1.21, −0.46)−1.32 (−1.64, −1.01)0.04†
Adjusted model 3
E-IVPD (mm Hg)0.85 (0.72, 0.99)0.91 (0.63, 1.20)0.79 (0.54, 1.05)0.76
ER-IVPD (mm Hg)−0.72 (−0.96, −0.49)−0.87 (−1.34, −0.40)−1.52 (−1.92, −1.13)0.006*†
A-IVPD (mm Hg)0.98 (0.85, 1.12)0.73 (0.46, 1.00)0.99 (0.73, 1.24)0.24
S-IVPD (mm Hg)1.74 (1.5, 1.98)1.47 (1.01, 1.92)1.86 (1.37, 2.34)0.34
SR-IVPD (mm Hg)−1.17 (−1.35, −0.99)−0.86 (−1.25, −0.47)−1.31 (−1.64, −0.99)0.11
  • Data are presented as mean (95% CI).

  • Unadjusted model; adjusted model 1: adjusted for clinical data (age, sex, African American ethnicity, BMI, coronary artery disease, eGFR and beta blocker, ACE-inhibitor, ARB, loop diuretic, and spironolactone use); adjusted model 2: model 1 additionally adjusted for echo parameters (Mitral E-wave velocity, E wave deceleration time, Mitral annular e’ septal); adjusted model 3: model 2 additionally adjusted for MRI data (LV mass index and EDVI).

  • *p<0.05 for No-HF vs HFpEF.

  • †p<0.05 for HFrEF vs HFpEF.

  • ‡p<0.05 for No-HF vs HFrEF.

  • EDVI, end-diastolic volumen index; eGFR, estimated glomerular filtration rate; HF, heart failure; HFpEF, HF with preserved ejection fraction; HFrEF, HF with reduced ejection fraction; IVPD, intraventricular pressure difference; LV, left ventricular.